News

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...
Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...
New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow ...
Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.
Loss of synapses and dysfunctional synapses in a region-specific way is important in Alzheimer’s. It’s actually the strongest correlate of cognitive decline, far more so than plaques and tangles, ...
The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...
Alzheimer's disease progression linked to microglia fat metabolism, potential new treatment target identified in recent study ...
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a progressive neurological disease with an ...
Glial cells support neurological structures, function, cognition, behaviours, physical skills, and motor coordination.
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.
The researchers discovered that STING, an immune molecule meant to protect the brain, may actually be making things worse as ...
Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...